Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer

Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer

17 Aug 2022 5:14 PM | Anonymous

Tsuyoshi Harada MSc, Tetsuya Tsuji MD, PhD, Junya Ueno, Yu Koishihara MSc, Nobuko Konishi MSc, Nanako Hijikata MD, Aiko Ishikawa MD, PhD, Daisuke Kotani MD, PhD, Takashi Kojima MD, PhD, Hisashi Fujiwara MD, PhD & Takeo Fujita MD, PhD 

Read Abstract: Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software